Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESDAD: EGCG for Cognitive Deficits in Down Syndrome
NCT01394796Phase 2Completed
- Sponsor
- Parc de Salut Mar
- Start
- May 2010
- Primary completion
- Feb 2011
01
Overview
A Phase 2 trial of epigallocatechin gallate in Down syndrome, sponsored by Parc de Salut Mar. Started May 2010; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT01394796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01394796.